Among men with HIV who achieved viral suppression, no significant differences were found versus healthy controls in quality of life, depression, or sexual dysfunction, supporting individual evaluation rather than HIV status-based assumptions.
Key Findings
Results
Quality of life scores were similar between virologically suppressed HIV-positive men and healthy male controls.
Measured using the EUROHIS-QOL 8 questionnaire
Study included 39 heterosexual men on cART with viral suppression and 60 healthy male controls
Mean age of HIV group was 39 years; controls were 41.5 years, with similar demographics
Median EUROHIS-QOL8 scores were similar between groups with no statistically significant difference reported
Results
Depression scores were similar between virologically suppressed HIV-positive men and healthy male controls.
Measured using the Beck Depression Inventory (BDI)
Median BDI scores were similar between the HIV group and controls
No statistically significant difference in depression prevalence was found between groups
Results
ASEX scores were statistically higher in HIV patients compared to controls, but this did not translate to a higher prevalence of sexual dysfunction by established criteria.
Measured using the Arizona Sexual Experience Scale (ASEX)
ASEX scores were higher in HIV patients (p = .032)
Despite higher ASEX scores, the difference did not result in a higher prevalence of sexual dysfunction based on established ASEX criteria
39 HIV-positive men and 60 healthy controls were compared
Results
BDI scores were strongly negatively correlated with EUROHIS-QOL8 scores in the HIV group and moderately negatively correlated in controls.
In the HIV group, BDI and EUROHIS-QOL8 were strongly negatively correlated (r = −.731, p < .001)
In the control group, the correlation was moderate (r = −.475, p < .001)
Quality of life decreased with increasing depressive symptoms in both groups
The stronger correlation in the HIV group suggests depression may have a greater impact on quality of life in this population
Methods
The study was designed as a case-control study comparing heterosexual men on combination antiretroviral therapy with viral suppression to healthy male controls.
39 heterosexual men on cART with viral suppression were enrolled in the HIV group
60 healthy male controls were enrolled for comparison
Participants completed three validated questionnaires: EUROHIS-QOL 8, Beck Depression Inventory (BDI), and Arizona Sexual Experience Scale (ASEX)
Only virologically suppressed individuals were included, reflecting a population with effective treatment
What This Means
This research suggests that men living with HIV who have their virus successfully controlled by antiretroviral medication experience similar quality of life, depression levels, and rates of sexual dysfunction compared to men without HIV. The study compared 39 HIV-positive men whose virus was suppressed to undetectable levels on combination antiretroviral therapy (cART) with 60 healthy men, using standardized questionnaires to measure well-being, depression, and sexual function. Although HIV-positive men scored slightly higher on a sexual experience scale, this did not translate into a meaningfully higher rate of clinical sexual dysfunction.
The study also found that depression was closely linked to quality of life in both groups, but this relationship was stronger in the HIV-positive group. This means that when HIV-positive men experienced more depressive symptoms, their quality of life dropped more sharply than it did for healthy men with similar depression levels, highlighting the importance of mental health support for people living with HIV.
These findings matter because they challenge the assumption that an HIV diagnosis automatically leads to worse mental health, sexual function, or overall quality of life. This research suggests that when HIV is effectively treated and the virus is suppressed, outcomes can be comparable to those of HIV-negative individuals, and that healthcare providers should evaluate each person individually rather than making assumptions based on HIV status alone.
Ö. Güler, Demir Akhan, Gamze Kara Sözen, S. Akhan. (2026). Quality of life, depression and sexual function in men living with HIV under effective antiretroviral therapy compared with healthy controls. Patient Related Outcome Measures. https://doi.org/10.1080/1179271X.2026.2664443